1-2 of 2
Jacques-Olivier Bay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)

Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Franck Morschhauser, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques-Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stéphanie Guidez, Michaël Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Mathilde Guillet, Roch Houot
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1573–1585.
https://doi.org/10.1182/bloodadvances.2023011727
Published: 2024
Includes: Supplemental data
Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Clinical Trials & Observations
Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant
Journal: Blood Advances
Blood Adv (2019) 3 (2): 184–186.
https://doi.org/10.1182/bloodadvances.2018028282
Published: 2019